NASDAQ
Infinity Pharmaceuticals, Inc. (INFIQ) has a free cash flow growth of 36.33% as of Friday, May 29, 2026. This represents a 402.98% increase compared to its 12-month average of -11.99%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.